Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 320

1.

Antimicrobial susceptibility patterns and MICs among non-photochromogenic rapidly growing Mycobacteroides and Mycolicibacterium species.

Yoshida S, Tsuyuguchi K, Chikamatsu K, Aono A, Takaki A, Mitarai S, Kobayashi T, Inoue Y, Suzuki K.

J Med Microbiol. 2019 Jul 8. doi: 10.1099/jmm.0.001035. [Epub ahead of print]

PMID:
31282855
2.

Evaluation of Q Gene Mycobacteria: A novel and easy nucleic acid chromatography method for mycobacterial species identification.

Chikamatsu K, Aono A, Kawai A, Hata H, Iwamoto T, Igarashi Y, Takaki A, Yamada H, Mitarai S.

J Microbiol Methods. 2019 Aug;163:105657. doi: 10.1016/j.mimet.2019.105657. Epub 2019 Jun 19.

PMID:
31228476
3.

Alcohol and hepatocellular carcinoma.

Matsushita H, Takaki A.

BMJ Open Gastroenterol. 2019 Apr 3;6(1):e000260. doi: 10.1136/bmjgast-2018-000260. eCollection 2019. Review.

4.

The relationship between the PD-L1 expression of surgically resected and fine-needle aspiration specimens for patients with pancreatic cancer.

Matsumoto K, Ohara T, Fujisawa M, Takaki A, Takahara M, Tanaka N, Kato H, Horiguchi S, Yoshida R, Umeda Y, Fushimi S, Yagi T, Matsukawa A, Okada H.

J Gastroenterol. 2019 Apr 29. doi: 10.1007/s00535-019-01586-6. [Epub ahead of print]

PMID:
31032528
5.

A case of Mycobacterium tuberculosis laboratory cross-contamination.

Takeda K, Murase Y, Kawashima M, Suzukawa M, Suzuki J, Yamane A, Igarashi Y, Chikamatsu K, Morishige Y, Aono A, Yamada H, Takaki A, Tamura A, Nagai H, Matsui H, Tohma S, Mitarai S.

J Infect Chemother. 2019 Aug;25(8):610-614. doi: 10.1016/j.jiac.2019.03.012. Epub 2019 Apr 11.

PMID:
30982725
6.

[Adefovir Dipivoxil-induced Fanconi's Syndrome and Osteomalacia Following Multiple Bone Fractures in a Patient with Chronic Hepatitis B].

Makita T, Kanzaki H, Onishi H, Ikeda A, Takaki A, Wada N, Takeuchi Y, Yasunaka T, Ikeda F, Shiraha H, Tanaka Y, Nishihara S, Murakawa K, Kitamura Y, Okada H, Sendo T.

Yakugaku Zasshi. 2019;139(4):641-645. doi: 10.1248/yakushi.18-00170. Japanese.

7.

Predictive Factors for Successful Vaccination Against Hepatitis B Surface Antigen in Patients Who Have Undergone Orthotopic Liver Transplantation.

Ikeda A, Takaki A, Yasunaka T, Oyama A, Adachi T, Wada N, Onishi H, Ikeda F, Shiraha H, Yoshida K, Kuise T, Nobuoka D, Yoshida R, Umeda Y, Yagi T, Fujiwara T, Okada H.

Acta Med Okayama. 2019 Feb;73(1):41-50. doi: 10.18926/AMO/56457.

8.

Efficacy and safety of glecaprevir and pibrentasvir treatment for 8 or 12 weeks in patients with recurrent hepatitis C after liver transplantation: a Japanese multicenter experience.

Ueda Y, Kobayashi T, Ikegami T, Miuma S, Mizuno S, Akamatsu N, Takaki A, Ishigami M, Takatsuki M, Sugawara Y, Maehara Y, Uemoto S, Seno H.

J Gastroenterol. 2019 Jul;54(7):660-666. doi: 10.1007/s00535-019-01561-1. Epub 2019 Feb 26.

PMID:
30806783
9.

Paradoxical Roles of Oxidative Stress Response in the Digestive System before and after Carcinogenesis.

Takaki A, Kawano S, Uchida D, Takahara M, Hiraoka S, Okada H.

Cancers (Basel). 2019 Feb 13;11(2). pii: E213. doi: 10.3390/cancers11020213. Review.

10.

POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33.

Hitomi Y, Ueno K, Kawai Y, Nishida N, Kojima K, Kawashima M, Aiba Y, Nakamura H, Kouno H, Kouno H, Ohta H, Sugi K, Nikami T, Yamashita T, Katsushima S, Komeda T, Ario K, Naganuma A, Shimada M, Hirashima N, Yoshizawa K, Makita F, Furuta K, Kikuchi M, Naeshiro N, Takahashi H, Mano Y, Yamashita H, Matsushita K, Tsunematsu S, Yabuuchi I, Nishimura H, Shimada Y, Yamauchi K, Komatsu T, Sugimoto R, Sakai H, Mita E, Koda M, Nakamura Y, Kamitsukasa H, Sato T, Nakamuta M, Masaki N, Takikawa H, Tanaka A, Ohira H, Zeniya M, Abe M, Kaneko S, Honda M, Arai K, Arinaga-Hino T, Hashimoto E, Taniai M, Umemura T, Joshita S, Nakao K, Ichikawa T, Shibata H, Takaki A, Yamagiwa S, Seike M, Sakisaka S, Takeyama Y, Harada M, Senju M, Yokosuka O, Kanda T, Ueno Y, Ebinuma H, Himoto T, Murata K, Shimoda S, Nagaoka S, Abiru S, Komori A, Migita K, Ito M, Yatsuhashi H, Maehara Y, Uemoto S, Kokudo N, Nagasaki M, Tokunaga K, Nakamura M.

Sci Rep. 2019 Jan 14;9(1):102. doi: 10.1038/s41598-018-36490-1.

11.

Analysis of 307 cases with drug-induced liver injury between 2010 and 2018 in Japan.

Aiso M, Takikawa H, Tsuji K, Kagawa T, Watanabe M, Tanaka A, Sato K, Sakisaka S, Hiasa Y, Takei Y, Ohira H, Ayada M, Hashimoto E, Kaneko S, Ueno Y, Ohmoto K, Takaki A, Torimura T, Matsuzaki Y, Tajiri K, Yoneda M, Ito T, Kato N, Ikejima K, Mochida S, Yasuda H, Sakamoto N.

Hepatol Res. 2019 Jan;49(1):105-110. doi: 10.1111/hepr.13288.

PMID:
30565816
12.

Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports.

Shibata Y, Nakatsuka A, Eguchi J, Miyamoto S, Masuda Y, Awazawa M, Takaki A, Yoshida R, Yagi T, Wada J.

J Med Case Rep. 2018 Dec 14;12(1):368. doi: 10.1186/s13256-018-1901-y.

13.

Non-alcoholic fatty liver disease in patients with autoimmune hepatitis.

Takahashi A, Arinaga-Hino T, Ohira H, Abe K, Torimura T, Zeniya M, Abe M, Yoshizawa K, Takaki A, Suzuki Y, Kang JH, Nakamoto N, Fujisawa T, Tanaka A, Takikawa H; Japan AIH Study Group (JAIHSG).

JGH Open. 2018 Mar 30;2(2):54-58. doi: 10.1002/jgh3.12046. eCollection 2018 Apr.

14.

Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae.

Aono A, Morimoto K, Chikamatsu K, Yamada H, Igarashi Y, Murase Y, Takaki A, Mitarai S.

J Infect Chemother. 2019 Feb;25(2):117-123. doi: 10.1016/j.jiac.2018.10.010. Epub 2018 Nov 14.

PMID:
30447882
15.

Monitoring serum proangiogenic cytokines from hepatocellular carcinoma patients treated with sorafenib.

Adachi T, Nouso K, Miyahara K, Oyama A, Wada N, Dohi C, Takeuchi Y, Yasunaka T, Onishi H, Ikeda F, Nakamura S, Shiraha H, Takaki A, Takabatake H, Fujioka SI, Kobashi H, Takuma Y, Iwadou S, Uematsu S, Takaguchi K, Hagihara H, Okada H; Okayama Liver Cancer Group.

J Gastroenterol Hepatol. 2019 Jun;34(6):1081-1087. doi: 10.1111/jgh.14535. Epub 2018 Dec 10.

PMID:
30402928
16.

A simplified pyrazinamidase test for pyrazinamide drug susceptibility in Mycobacterium tuberculosis.

Aono A, Chikamatsu K, Yamada H, Igarashi Y, Murase Y, Takaki A, Mitarai S.

J Microbiol Methods. 2018 Nov;154:52-54. doi: 10.1016/j.mimet.2018.09.018. Epub 2018 Oct 11.

PMID:
30316980
17.

Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey.

Takahashi A, Moriya K, Ohira H, Arinaga-Hino T, Zeniya M, Torimura T, Abe M, Takaki A, Kang JH, Inui A, Fujisawa T, Yoshizawa K, Suzuki Y, Nakamoto N, Koike K, Yoshiji H, Goto A, Tanaka A, Younossi ZM, Takikawa H; Japan AIH Study Group.

PLoS One. 2018 Oct 4;13(10):e0204772. doi: 10.1371/journal.pone.0204772. eCollection 2018.

18.

Mycolicibacterium smegmatis, Basonym Mycobacterium smegmatis, Expresses Morphological Phenotypes Much More Similar to Escherichia coli Than Mycobacterium tuberculosis in Quantitative Structome Analysis and CryoTEM Examination.

Yamada H, Yamaguchi M, Igarashi Y, Chikamatsu K, Aono A, Murase Y, Morishige Y, Takaki A, Chibana H, Mitarai S.

Front Microbiol. 2018 Sep 11;9:1992. doi: 10.3389/fmicb.2018.01992. eCollection 2018.

19.

Six species of nontuberculous mycobacteria carry non-identical 16S rRNA gene copies.

Takeda K, Chikamatsu K, Igarashi Y, Morishige Y, Murase Y, Aono A, Yamada H, Takaki A, Mitarai S.

J Microbiol Methods. 2018 Dec;155:34-36. doi: 10.1016/j.mimet.2018.08.012. Epub 2018 Aug 27.

PMID:
30165088
20.

Mixed HCV Infection of Genotype 1B and Other Genotypes Influences Non-response during Daclatasvir + Asunaprevir Combination Therapy.

Wada N, Ikeda F, Mori C, Takaguchi K, Fujioka SI, Kobashi H, Morimoto Y, Kariyama K, Sakaguchi K, Hashimoto N, Moriya A, Kawaguchi M, Miyatake H, Hagihara H, Kubota J, Takayama H, Takeuchi Y, Yasunaka T, Takaki A, Iwasaki Y, Okada H.

Acta Med Okayama. 2018 Aug;72(4):401-406. doi: 10.18926/AMO/56178.

21.

Symptoms and health-related quality of life in Japanese patients with primary biliary cholangitis.

Yagi M, Tanaka A, Abe M, Namisaki T, Yoshiji H, Takahashi A, Ohira H, Komori A, Yamagiwa S, Kikuchi K, Yasunaka T, Takaki A, Ueno Y, Honda A, Matsuzaki Y, Takikawa H.

Sci Rep. 2018 Aug 22;8(1):12542. doi: 10.1038/s41598-018-31063-8.

22.

Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation.

Inoue Y, Endo S, Matsuno N, Kikukawa Y, Shichijo T, Koga K, Takaki A, Iwanaga K, Nishimura N, Fuji S, Fukuda T, Nosaka K, Matsuoka M.

Bone Marrow Transplant. 2019 Feb;54(2):338-342. doi: 10.1038/s41409-018-0291-5. Epub 2018 Aug 16. No abstract available.

PMID:
30116017
23.

Beneficial and Paradoxical Roles of Anti-Oxidative Nutritional Support for Non-Alcoholic Fatty Liver Disease.

Uchida D, Takaki A, Adachi T, Okada H.

Nutrients. 2018 Jul 27;10(8). pii: E977. doi: 10.3390/nu10080977. Review.

24.

Development of an 123I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease.

Kamiya Y, Ota S, Tanaka Y, Yamashita K, Takaki A, Ito S.

Asia Ocean J Nucl Med Biol. 2018 Spring;6(2):129-138. doi: 10.22038/aojnmb.2018.10595.

25.

Prevention of aerosol isolation of nontuberculous mycobacterium from the patient's bathroom.

Morimoto K, Aono A, Murase Y, Sekizuka T, Kurashima A, Takaki A, Sasaki Y, Igarashi Y, Chikamatsu K, Goto H, Yamada H, Kuroda M, Mitarai S.

ERJ Open Res. 2018 Jul 3;4(3). pii: 00150-2017. doi: 10.1183/23120541.00150-2017. eCollection 2018 Jul.

26.

First case of sexually transmitted asymptomatic female genital tuberculosis from spousal epididymal tuberculosis diagnosed by active screening.

Kimura M, Araoka H, Baba H, Okada C, Murase Y, Takaki A, Mitarai S, Yoneyama A.

Int J Infect Dis. 2018 Aug;73:60-62. doi: 10.1016/j.ijid.2018.05.021. Epub 2018 Jun 4.

27.

Successful treatment by pembrolizumab in a patient with end-stage renal disease with advanced non-small cell lung cancer and high PD-L1 expression.

Ishizuka S, Sakata S, Yoshida C, Takaki A, Saeki S, Nakamura K, Fujii K.

Respir Investig. 2018 Jul;56(4):361-364. doi: 10.1016/j.resinv.2018.03.005. Epub 2018 May 10.

PMID:
29764752
28.

A subclinical high tricuspid regurgitation pressure gradient independent of the mean pulmonary artery pressure is a risk factor for the survival after living donor liver transplantation.

Saragai Y, Takaki A, Umeda Y, Matsusaki T, Yasunaka T, Oyama A, Kaku R, Nakamura K, Yoshida R, Nobuoka D, Kuise T, Takagi K, Adachi T, Wada N, Takeuchi Y, Koike K, Ikeda F, Onishi H, Shiraha H, Nakamura S, Morimatsu H, Ito H, Fujiwara T, Yagi T, Okada H.

BMC Gastroenterol. 2018 May 15;18(1):62. doi: 10.1186/s12876-018-0793-z.

29.

New Left Lobe Transplantation Procedure with Caval Reconstruction Using an Inverted Composite Graft for Chronic Budd-Chiari Syndrome in Living-Donor Liver Transplantation-A Case Report.

Yagi T, Takagi K, Yoshida R, Umeda Y, Nobuoka D, Kuise T, Fujiwara T, Takaki A.

Transplant Proc. 2018 May;50(4):1192-1195. doi: 10.1016/j.transproceed.2017.11.078.

30.

Risk Analysis for Invasive Fungal Infection after Living Donor Liver Transplantation: Which Patient Needs Potent Prophylaxis?

Utsumi M, Umeda Y, Yagi T, Nagasaka T, Shinoura S, Yoshida R, Nobuoka D, Kuise T, Fuji T, Takagi K, Takaki A, Fujiwara T.

Dig Surg. 2019;36(1):59-66. doi: 10.1159/000486548. Epub 2018 Apr 12.

PMID:
29649828
31.

Severe interstitial pneumonia associated with anti-PD-1 immune checkpoint antibody after talc slurry pleurodesis.

Sakata S, Matsuoka Y, Kawahara K, Kakiuchi Y, Takaki A, Hirosue A, Yoshida R, Saeki S, Fujii K, Nakayama H.

Respir Investig. 2018 Mar;56(2):195-198. doi: 10.1016/j.resinv.2017.11.006. Epub 2017 Dec 21.

PMID:
29548660
32.

Reversible Restrictive Lung Disease in Pseudomesotheliomatous Carcinoma in a Lung Harboring a HER2-mutation.

Sakata S, Sakamoto Y, Takaki A, Ishizuka S, Saeki S, Fujii K.

Intern Med. 2018 Aug 1;57(15):2223-2226. doi: 10.2169/internalmedicine.9612-17. Epub 2018 Mar 9.

33.

Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey.

Joshita S, Yoshizawa K, Umemura T, Ohira H, Takahashi A, Harada K, Hiep NC, Tsuneyama K, Kage M, Nakano M, Kang JH, Koike K, Zeniya M, Yasunaka T, Takaki A, Torimura T, Abe M, Yokosuka O, Tanaka A, Takikawa H; Japan Autoimmune Hepatitis Study Group (JAIHSG).

J Gastroenterol. 2018 Sep;53(9):1079-1088. doi: 10.1007/s00535-018-1444-4. Epub 2018 Feb 23.

PMID:
29476251
34.

Transcatheter Arterial Chemoembolization to Reduce Size of Hepatocellular Carcinoma before Radiofrequency Ablation.

Ako S, Nakamura S, Nouso K, Dohi C, Wada N, Morimoto Y, Takeuchi Y, Yasunaka T, Kuwaki K, Onishi H, Ikeda F, Shiraha H, Takaki A, Okada H.

Acta Med Okayama. 2018 Feb;72(1):47-52. doi: 10.18926/AMO/55662.

35.

A Simple Non-invasive I-123-IMP Autoradiography Method Developed by Modifying the Simple Non-invasive I-123-IMP Microsphere Method.

Ofuji A, Nagaoka R, Yamashita K, Takaki A, Ito S.

Asia Ocean J Nucl Med Biol. 2018 Winter;6(1):50-56. doi: 10.22038/aojnmb.2017.9555.

36.

Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection.

Kumada H, Watanabe T, Suzuki F, Ikeda K, Sato K, Toyoda H, Atsukawa M, Ido A, Takaki A, Enomoto N, Kato K, Alves K, Burroughs M, Redman R, Pugatch D, Pilot-Matias TJ, Krishnan P, Oberoi RK, Xie W, Chayama K.

J Gastroenterol. 2018 May;53(5):689. doi: 10.1007/s00535-017-1409-z.

37.

Evaluation of PyroMark Q24 pyrosequencing as a method for the identification of mycobacteria.

Chikamatsu K, Aono A, Hata H, Igarashi Y, Takaki A, Yamada H, Sakashita K, Mitarai S.

Diagn Microbiol Infect Dis. 2018 Jan;90(1):35-39. doi: 10.1016/j.diagmicrobio.2017.09.002. Epub 2017 Sep 15.

PMID:
29107416
38.

Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection.

Kumada H, Watanabe T, Suzuki F, Ikeda K, Sato K, Toyoda H, Atsukawa M, Ido A, Takaki A, Enomoto N, Kato K, Alves K, Burroughs M, Redman R, Pugatch D, Pilot-Matias TJ, Krishnan P, Oberoi RK, Xie W, Chayama K.

J Gastroenterol. 2018 Apr;53(4):566-575. doi: 10.1007/s00535-017-1396-0. Epub 2017 Oct 20. Erratum in: J Gastroenterol. 2017 Nov 13;:.

39.

Prediction of Local Transmission of Mycobacterium tuberculosis Isolates of a Predominantly Beijing Lineage by Use of a Variable-Number Tandem-Repeat Typing Method Incorporating a Consensus Set of Hypervariable Loci.

Murase Y, Izumi K, Ohkado A, Aono A, Chikamatsu K, Yamada H, Igarashi Y, Takaki A, Mitarai S.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e01016-17. doi: 10.1128/JCM.01016-17. Print 2018 Jan.

40.

Living Donor Liver Transplantation for Acute Liver Failure : Comparing Guidelines on the Prediction of Liver Transplantation.

Yoshida K, Umeda Y, Takaki A, Nagasaka T, Yoshida R, Nobuoka D, Kuise T, Takagi K, Yasunaka T, Okada H, Yagi T, Fujiwara T.

Acta Med Okayama. 2017 Oct;71(5):381-390. doi: 10.18926/AMO/55435.

41.

Mycobacterium abscessus and massiliense lung infection during macrolide treatment for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.

Miyake N, Chong Y, Nishida R, Takenaka K, Kato K, Miyamoto T, Aono A, Takaki A, Mitarai S, Shimoda S, Shimono N, Akashi K.

J Infect Chemother. 2018 Jan;24(1):78-81. doi: 10.1016/j.jiac.2017.08.011. Epub 2017 Oct 6.

PMID:
28988958
42.

Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.

Igarashi Y, Chikamatsu K, Aono A, Yi L, Yamada H, Takaki A, Mitarai S.

Diagn Microbiol Infect Dis. 2017 Dec;89(4):276-281. doi: 10.1016/j.diagmicrobio.2017.08.016. Epub 2017 Aug 25.

PMID:
28974394
43.

Hepatic and Gastric Involvement in a Case of Systemic Sarcoidosis Presenting with Rupture of Esophageal Varices.

Saito H, Ohmori M, Iwamuro M, Tanaka T, Wada N, Yasunaka T, Takaki A, Okada H.

Intern Med. 2017 Oct 1;56(19):2583-2588. doi: 10.2169/internalmedicine.8768-16. Epub 2017 Sep 6.

44.

Uptake Index of 123I-metaiodobenzylguanidine Myocardial Scintigraphy for Diagnosing Lewy Body Disease.

Kamiya Y, Ota S, Okumiya S, Yamashita K, Takaki A, Ito S.

Asia Ocean J Nucl Med Biol. 2017 Winter;5(1):37-43. doi: 10.22038/aojnmb.2016.7972.

45.

Corrigendum to "Safety and Efficacy of Small Bowel Examination by Capsule Endoscopy for Patients before Liver Transplantation".

Kawano S, Takaki A, Iwamuro M, Yasunaka T, Kono Y, Miura K, Inokuchi T, Kawahara Y, Umeda Y, Yagi T, Okada H.

Biomed Res Int. 2017;2017:6418529. doi: 10.1155/2017/6418529. Epub 2017 Jul 3.

46.

In vitro activity of sitafloxacin against Mycobacterium tuberculosis with gyrA/B mutations isolated in Japan.

Yi L, Aono A, Chikamatsu K, Igarashi Y, Yamada H, Takaki A, Mitarai S.

J Med Microbiol. 2017 Jun 9. doi: 10.1099/jmm.0.000493. [Epub ahead of print]

PMID:
28598311
47.

Association between periodontitis and prognosis of pancreatobiliary tract cancer: A pilot study.

Maruyama T, Tomofuji T, Machida T, Kato H, Tsutsumi K, Uchida D, Takaki A, Yoneda T, Miyai H, Mizuno H, Ekuni D, Okada H, Morita M.

Mol Clin Oncol. 2017 May;6(5):683-687. doi: 10.3892/mco.2017.1220. Epub 2017 Apr 10.

48.

Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients.

Nguyen Canh H, Harada K, Ouchi H, Sato Y, Tsuneyama K, Kage M, Nakano M, Yoshizawa K, Takahashi A, Abe M, Kang JH, Koike K, Inui A, Fujisawa T, Takaki A, Arinaga-Hino T, Torimura T, Suzuki Y, Fujiwara K, Zeniya M, Ohira H, Tanaka A, Takikawa H; Intractable Liver and Biliary Diseases Study Group of Japan.

J Clin Pathol. 2017 Nov;70(11):961-969. doi: 10.1136/jclinpath-2016-204271. Epub 2017 Apr 20.

PMID:
28428284
49.

Early Chimerism After Liver Transplantation Reflects the Clinical Course of Recurrent Hepatitis C.

Utsumi M, Takaki A, Umeda Y, Koike K, Napier SC, Watanabe N, Shinoura S, Yoshida R, Nobuoka D, Yasunaka T, Oto T, Araki M, Yamamoto K, Fujiwara T, Yagi T.

Ann Transplant. 2017 Mar 24;22:156-165.

50.

Current Metabolic Status Affects Urinary Liver-Type Fatty-Acid Binding Protein in Normoalbuminuric Patients With Type 2 Diabetes.

Ito H, Yamashita H, Nakashima M, Takaki A, Yukawa C, Matsumoto S, Omoto T, Shinozaki M, Nishio S, Abe M, Antoku S, Mifune M, Togane M.

J Clin Med Res. 2017 Apr;9(4):366-373. doi: 10.14740/jocmr2934w. Epub 2017 Feb 21.

Supplemental Content

Loading ...
Support Center